BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16586043)

  • 21. Long-term outcome of mothers of children with complete congenital heart block.
    Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
    Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.
    Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P
    Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neonatal lupus syndrome].
    Iwamoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Feb; 28(1):4-9. PubMed ID: 15744116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasone.
    Theander E; Brucato A; Gudmundsson S; Salomonsson S; Wahren-Herlenius M; Manthorpe R
    J Rheumatol; 2001 Feb; 28(2):373-6. PubMed ID: 11246681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type I IFN system activation in newborns exposed to Ro/SSA and La/SSB autoantibodies in utero.
    Hedlund M; Thorlacius GE; Ivanchenko M; Ottosson V; Kyriakidis N; Lagnefeldt L; Tingström J; Sirsjö A; Bengtsson AA; Aronsson E; Gemzell-Danielsson K; Ronnblom L; Bergman G; Espinosa A; Sonesson SE; Eloranta ML; Wahren-Herlenius M
    RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.
    Costedoat-Chalumeau N; Georgin-Lavialle S; Amoura Z; Piette JC
    Lupus; 2005; 14(9):660-4. PubMed ID: 16218462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry.
    Buyon JP; Hiebert R; Copel J; Craft J; Friedman D; Katholi M; Lee LA; Provost TT; Reichlin M; Rider L; Rupel A; Saleeb S; Weston WL; Skovron ML
    J Am Coll Cardiol; 1998 Jun; 31(7):1658-66. PubMed ID: 9626848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of maternal subclinical Sjögren's syndrome associated with congenital heart block.
    Imai F; Suzuki T; Katagiri T; Ohno S; Tanaka M; Dohi Y
    Jpn J Med; 1991; 30(1):39-42. PubMed ID: 1865576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of heart block in children of SSA/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern.
    Ambrosi A; Salomonsson S; Eliasson H; Zeffer E; Skog A; Dzikaite V; Bergman G; Fernlund E; Tingström J; Theander E; Rydberg A; Skogh T; Öhman A; Lundström U; Mellander M; Winqvist O; Fored M; Ekbom A; Alfredsson L; Källberg H; Olsson T; Gadler F; Jonzon A; Kockum I; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2012 Mar; 71(3):334-40. PubMed ID: 21953338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete congenital heart block followed by anti-Ro/SSA in adult life. Studies of an informative family.
    Reichlin M; Friday K; Harley JB
    Am J Med; 1988 Feb; 84(2):339-44. PubMed ID: 3261539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More to death than dying: apoptosis in the pathogenesis of SSA/Ro-SSB/La-associated congenital heart block.
    Clancy RM; Buyon JP
    Rheum Dis Clin North Am; 2004 Aug; 30(3):589-602, x. PubMed ID: 15261343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.
    Markham AJ; Rasmussen SE; Salmon JE; Martinez-Ortiz W; Cardozo TJ; Clancy RM; Buyon JP
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25994441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.
    Brito-Zerón P; Pasoto SG; Robles-Marhuenda A; Mandl T; Vissink A; Armagan B; Praprotnik S; Nocturne G; Sebastian A; Fernandes Moça Trevisani V; Retamozo S; Acar-Denizli N; Wiland P; Sisó-Almirall A; Bootsma H; Mariette X; Ramos-Casals M; Kostov B;
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):95-102. PubMed ID: 33025893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibody-associated congenital heart block: outcome in mothers and children.
    Waltuck J; Buyon JP
    Ann Intern Med; 1994 Apr; 120(7):544-51. PubMed ID: 8116991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero.
    Mofors J; Eliasson H; Ambrosi A; Salomonsson S; Skog A; Fored M; Ekbom A; Bergman G; Sonesson SE; Wahren-Herlenius M
    Ann Rheum Dis; 2019 May; 78(5):696-703. PubMed ID: 30808622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study.
    Brucato A; Doria A; Frassi M; Castellino G; Franceschini F; Faden D; Pisoni MP; Solerte L; Muscarà M; Lojacono A; Motta M; Cavazzana I; Ghirardello A; Vescovi F; Tombini V; Cimaz R; Gambari PF; Meroni PL; Canesi B; Tincani A
    Lupus; 2002; 11(11):716-21. PubMed ID: 12475001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Ro/SSA autoantibodies over time in mothers of children with congenital complete heart block.
    Franceschini F; Brucato A; Quinzanini M; Calzavara-Pinton PG; Coluccio E; Cavazzana I; Cattaneo R
    Clin Exp Rheumatol; 1999; 17(5):634-5. PubMed ID: 10544858
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-SSA/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA/Ro positive pregnant patients with and without autoimmune diseases.
    Fredi M; Argolini LM; Angeli F; Trespidi L; Ramoni V; Zatti S; Vojinovic T; Donzelli D; Gazzola FG; Xoxi B; Andreoli L; Lojacono A; Ferrazzi E; Montecucco C; Chighizola CB; Meroni PL; Franceschini F; Cimaz R; Caporali R; Tincani A; Gerosa M
    Clin Exp Rheumatol; 2023 Mar; 41(3):685-693. PubMed ID: 36377571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.